All‐oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub‐analysis in Asian patients from the HALLMARK DUAL study

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 36, Iss. 10, 2016-10 ,pp. : 1433-1441

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of hepatitis B virus, hepatitis D virus and other determinants on suppression of hepatitis C viraemia in HIV infected patients with chronic HCV infection: A longitudinal evaluation

By Antonucci Giorgio   Vairo Francesco   Iacomi Fabio   Comandini Ubaldo Visco   Solmone Mariacarmela   Piselli Pierluca   Boumis Evangelo   Lauria Francesco Nicola   Capobianchi Maria Rosaria   Ippolito Giuseppe   Puro Vincenzo  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 11-12, 2008-11 ,pp. : 928-934

Informa Healthcare

Access to resources Recommend Favorite

P054: The response rates of current chronic viral Hepatitis B treatments

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 46-47

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 41-49

Karger

Access to resources Recommend Favorite

P027: Association between the viral basal core promoter and precore mutations with the different clinical stages of patients with chronic Hepatitis B virus infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 32-32

John Wiley & Sons Inc

Access to resources Recommend Favorite